Categories: News

New exoplan 3.0 Galway Now Available

Latest Release Offers Edentulous Case Planning and Design of Respective Surgical Guides

DARMSTADT, Germany, Dec. 21, 2020 /PRNewswire/ — Today, exocad GmbH (exocad), an Align Technology, Inc. company, announced the availability of exoplan 3.0 Galway, the latest version of its implant planning software. The new release supports planning of edentulous cases, including design of surgical guides.

“We are excited to announce the release of exoplan 3.0 Galway and enthused about the new possibilities it presents for guided surgery,” said Tillmann Steinbrecher, exocad CEO. “exoplan 3.0 Galway will provide dental practices and laboratories with a digital workflow that offers maximum flexibility and builds on exocad’s mission to make CAD design as easy as using an app on a cell phone.”

exoplan 3.0 Galway is a powerful, open, and efficient software package for virtual implant planning. Customized surgical guides can be designed using the Guide Creator software module, and then produced on site – in a laboratory, dental practice, or an external production center. The software comes in a new, modern user interface, inspired by the Google Material Design system.

With more than 40 new features, as well as enhancements to over 60 existing functionalities, the Galway release represents a major expansion of capabilities in guided surgery and improved integration with DentalCAD, exocad’s dental CAD software.

Key highlights of exoplan 3.0 Galway include:

  • Planning of edentulous cases and design of the respective surgical guides, including necessary tools, such as dual scan protocol, anchor pin placement, and fixation guide
  • Surgical and fixation guides can be freely designed or based on a prosthesis scan
  • New tools to speed up the entire planning process
  • Improved implant selection dialog
  • Automatic panoramic curve detection
  • More implant libraries, now with over 500 implant systems and over 8,500 implants from more than 80 manufacturers
  • Virtual tooth extraction on optical scans
  • Possibility to easily mark sinus cavity and check if implants are intruding

All exocad solutions are based on the same technical platform with an open architecture, ensuring the seamless functionality of the digital workflow: from virtual prosthesis-oriented implant planning with exoplan and designing surgical guides with Guide Creator, to planning and producing the implant-supported, temporary, and final restorations with DentalCAD, exocad’s dental CAD software.

“As the world’s premier OEM supplier of dental CAD software, we provide the symbiosis of prosthetic and implant planning,” said Steinbrecher. “Users can achieve predictable results in a cost and time-efficient manner, which can ultimately result in increased customer satisfaction.”

exoplan 3.0 Galway is now available in the EU and other select markets.

exocad names its releases after current EU “European Capitals of Culture” and selected the Irish city of Galway for this year’s release.

Additional information is available at exocad.com/exoplan

About exocad GmbH
exocad GmbH, an Align Technology, Inc. company, is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit exocad.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-exoplan-3-0-galway-now-available-301196870.html

SOURCE exocad GmbH

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

2 hours ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

2 hours ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

2 hours ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

2 hours ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

2 hours ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

2 hours ago